Keyphrases
Adult Patients
11%
Allogeneic Peripheral Blood Stem Cell Transplantation
100%
Antibiotic Duration
11%
Antibiotic Therapy
11%
Bacteremia
11%
Bloodstream Infection
22%
Bone Marrow Mononuclear Cells
11%
Clinical Outcomes
11%
Cost Savings
22%
Delayed Administration
100%
Delayed Initiation
11%
Duration of Infection
11%
Early Administration
11%
Early Initiation
11%
Febrile Neutropenia
33%
Fever Duration
22%
Filgrastim
100%
Granulocyte Colony-stimulating Factor (G-CSF)
100%
High-dose Chemotherapy
11%
Length of Hospital Stay
33%
Neutropenia
11%
Neutrophil Engraftment
100%
No Adverse Effect
11%
No Significant Difference
22%
Pediatric Patients
100%
Peripheral Blood Stem Cells
11%
Platelet Engraftment
22%
Prophylactic Antibiotics
11%
Retrospective Review
11%
Medicine and Dentistry
Adverse Event
11%
Antibiotic Therapy
22%
Autologous Peripheral Blood Stem Cell Transplantation
100%
Bloodstream Infection
33%
Engraftment
100%
Febrile Neutropenia
33%
Filgrastim
100%
Granulocyte Colony Stimulating Factor
100%
Health Care Cost
33%
High Dose Chemotherapy
11%
Neutropenia
11%
Neutrophil
100%
Pediatrics Patient
100%
Peripheral Blood Stem Cell
11%
Platelet
22%
Nursing and Health Professions
Adverse Event
11%
Antibiotic Therapy
22%
Autologous Peripheral Blood Stem Cell Transplantation
100%
Bloodstream Infection
33%
Clinical Outcome
11%
Cost Control
22%
Drug Megadose
11%
Engraftment
100%
Febrile Neutropenia
33%
Filgrastim
100%
Granulocyte Colony Stimulating Factor
100%
Neutropenia
11%
Pediatrics Patient
100%
Immunology and Microbiology
Autologous Peripheral Blood Stem Cell Transplantation
100%
Blood Flow
22%
Drug Megadose
11%
Engraftment
100%
Filgrastim
100%
Granulocyte Colony-Stimulating Factor
100%
Infection
22%
Neutrophil
100%
Peripheral Blood Stem Cell
11%
Platelet
22%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
11%
Antibiotic Therapy
22%
Bloodstream Infection
33%
Febrile Neutropenia
33%
Filgrastim
100%
Granulocyte Colony Stimulating Factor
100%
High Dose Chemotherapy
11%
Neutropenia
11%